April 23–25, 2024

Boston, USA

Join ARMGO at the World Orphan Drug Congress USA, Boston, USA, April 23 – 25, 2024

ARMGO Pharma will be attending World Orphan Drug Congress USA 2024, one of the biggest and most influential meetings for stakeholders interested in orphan drugs and rare diseases. The event will bring together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers.

The event is a great opportunity to meet and network with professionals from all disciplines to advance orphan drug development and enable faster access to potentially life-saving therapies, like ARM210, ARMGO’s clinical-stage orphan drug candidate for catecholaminergic polymorphic ventricular tachycardia (CPVT) and Ryanodine Receptor 1 Related Myopathy (RYR1-RM).

The event will take place in Boston, USA.

Request a meeting with us via ARMGO’s website.

Attendee:

Yael Webb, PhD, JD Chief Operating Officer & General Counsel

Hermann-Josef Kaiser, PhD, Vice President Business Development